Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: Proton relaxation mechanisms and optimal MR imaging parameters

Magnetic Resonance in Medical Sciences

Volumn 5, Issue 2, 2006, Pages 89-98

  Tanimoto, Akihiro ^a   Mukai, Makio ^a   Kuribayashi, Sachio ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Contrast media; Hepatitis; Iron; Liver; Magnetic resonance

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; IRON; OXIDE; PROTON; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ARTICLE; CLUSTER ANALYSIS; CONFOCAL MICROSCOPY; CYTOLOGY; DISEASE MODEL; HEPATITIS; IMAGE ENHANCEMENT; INJURY; LIVER; MACROPHAGE; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT; SIGNAL PROCESSING; SPRAGUE DAWLEY RAT;

ANIMALS; CLUSTER ANALYSIS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; HEPATITIS; IMAGE ENHANCEMENT; IRON; LIVER; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, CONFOCAL; OXIDES; PROTONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 39049179814     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.5.89     Document Type: Article

References (35)

1. Yamashita Y, Yamamoto H, Hirai A, Yoshimatsu S, Baba Y, Takahashi M. MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: influence of liver dysfunction and parenchymal pathology. Abdom Imaging 1996; 21: 318-323.
2. Arnold P, Ward J, Wilson D, Ashley Guthrie J, Robinson PJ. Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxidess in patients with advanced disease. Magn Reson Imaging 2003; 21:695-700.
3. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990; 174:797-801.
4. Lucidarme O, Baleston F, Cadi M, et al. Noninvasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 2003; 13:467-474.
5. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxide on proton relaxivity. Magn Reson Imaging 1988; 6:647-653.
6. Majumdar S, Gore JC. Studies of diffusion in random fields produced by variations in susceptibility. J Magn Reson 1988; 78:41-55.
7. Muller RN, Gillis P, Moiny F, Roch A. Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med 1991; 22:178-182.
8. Josephson L, Groman EV, Menz E, Lewis JM, Bengele H. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn Reson Imaging 1990; 8:637-646.
9. Tanimoto A, Pouliquen D, Kreft BP, Stark DD. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. J Magn Reson Imaging 1994; 4:653-657.
10. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imaging 2001; 14:72-77.
11. Tanimoto A, Yuasa Y, Shinmoto H, et al. Superparamagnetic iron oxide mediated hepatic signal change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002; 222:661-666.
12. Stark DD, Bass NM, Moss AA, et al. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983; 148:743-751.
13. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13:661-674.
14. Stark DD, Hendrick RE, Hahn PF, Ferrucci JT Jr. Motion artifact reduction with fast spin-echo imaging. Radiology 1987; 164:183-191.
15. Thickman D, Hendrick RE, Jerjian KA, Schanker CS. Liver-lesion tissue contrast on MR images: Effect of iron oxide concentration and magnetic field strength. Radiology 1990; 176:557-562.
16. Shiomi M, Wakabayashi Y, Sano T, et al. Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 1998; 27:108-115.
17. Iigou Y, Suematsu M, Higashida T, et al. In vivo constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. Am J Physiol 1997; 273:H138-147.
18. Product information sheet for polystyrene latex beads. Sigma, http://www.sigmaaldrich.com
19. Kawamura Y, Endo K, Watanabe Y, et al. Use of magnetite particles as a contrast agent for MR imaging of the liver. Radiology 1990; 174:357-360.
20. Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988; 9:356-362.
21. Romert P, Quistorff B, Bhenke O. Histological evaluation of the zonation of colloidal gold uptake by the rat liver. Tissue Cell 1993; 25:19-32.
22. Elias H. A re-examination of the structure of the mammalian liver; the hepatic lobule and its relation to the vascular and biliary systems. Am J Anat 1949; 85:379-456.
23. Reva RC, Chen DCP, Fajman WA. Hepatic scintigraphy, In: Bernardino ME, Sones PJ Jr, eds. Hepatic radiography. New York: Macmillan Publishing Company, 1984; 50-81.
24. Denardo SJ, Bell GB, Denardo GL, et al. Diagnosis of cirrhosis and hepatitis by quantitative hepatic and other reticuloendothelial clearance rates. J Nucl Med 1976; 17:449-459.
25. Waxman AD. Scintigraphic evaluation of diffuse hepatic disease. Semin Nucl Med 1982; 12:75-88.
26. Bekerman C, Gottschalk A. Diagnostic signifi-cance of the relative uptake of liver compared with spleen in 99m Tc-sulfur colloid scintiphotography. J Nucl Med 1971; 12:237-240.
27. Marzi I, Walcher F, Buhren V. Macrophage activation and leukocyte adhesion after liver transplantation. Am J Physiol 1993; 265:G172-177.
28. Suzuki S, Nakamura S, Serizawa A, et al. Role of KCs and the spleen in modulation of endotoxininduced liver injury after partial hepatectomy. Hepatology 1996; 24:219-225.
29. 1-weighted MRI. J Comput Assist Tomogr 2000; 24:648-651.
30. Kato N, Ihara S, Tsujimoto T, Miyazawa T. Effect of resovist on rats with different severities of liver cirrhosis. Invest Radiol 2002; 37:292-298.
31. Kreft B, Block W, Dombrowski F, et al. Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model. AJR Am J Roentgenol 1998; 170:661-668.
32. Canalese J, Gove CD, Gimson AE, Wilkinson SP, Wardle EN, Williams R. Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 1982; 23:265-269.
33. Paumgartner G, Longueville J, Leevy CM. Phagocytic activity in experimental liver injury. Exp Mol Pathol 1968; 9:161-176.
34. Lloyd RS, Triger DR. Studies on hepatic uptake of antigen. III. Studies of liver macrophage function in normal rats and following carbon tetrachloride administration. Immunology 1975; 29:253-263.
35. Yamamoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195:106-112.